TC
CLCD

TFS Capital’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

TFS Capital’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,220
Closed -$226K – 997
2016
Q4 		$226K Sell
6,220
-3,611
-37% -$128K 0.06% 485
2016
Q3 		$375K Buy
+9,831
New +$145K 0.09% 366

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

TFS Capital's CLCD Position: Q1 2017 in Review

TFS Capital sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 6,220 shares — an estimated $226K sold.

TFS Capital first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $375K in Q3 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • TFS Capital reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • TFS Capital sold 6,220 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $226K.
  • TFS Capital first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
  • TFS Capital's CoLucid Pharmaceuticals, Inc. position peaked at $375K in Q3 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on TFS Capital's 13F filing for Q1 2017, filed 5 May 2017.